Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing incidence of thyroid disorders
3.2.1.2 Advancements in diagnostic technologies
3.2.1.3 Increasing healthcare expenditure
3.2.1.4 Rising number of screening programs
3.2.2 Industry pitfalls & challenges
3.2.2.1 Stringent regulatory scenario
3.2.2.2 High cost of diagnostic tests
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Instruments
5.3 Reagent & kits
5.4 Other products
Chapter 6 Market Estimates and Forecast, By Test Type, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 TSH (thyroid stimulating hormone) test
6.3 T4 (thyroxine) test
6.4 T3 (triiodothyronine) test
6.5 Free T4 test
6.6 Free T3 test
6.7 Other test types
Chapter 7 Market Estimates and Forecast, By End-Use, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospitals & clinics
7.3 Diagnostic laboratories
7.4 Research & academic institutes
7.5 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 Saudi Arabia
8.6.2 South Africa
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 bioMerieux S.A.
9.3 Bio-Rad Laboratories, Inc.
9.4 Cipla Limited
9.5 Danaher Corporation
9.6 DiaSorin S.p.A.
9.7 F. Hoffmann-La Roche Ltd.
9.8 Quidelortho Corporation
9.9 Randox Laboratories Ltd.
9.10 Siemens Healthineers AG
9.11 Thermo Fisher Scientific Inc.
